IL6 and rectal cancer: While our study focused on the prognostic value of NLR, PLR, and CEA, previous research has identified other serum biomarkers, including IL-6, TNF-αR2, adiponectin, and C-reactive protein as potential indicators of prognosis in rectal cancer [54,55,56].